Tag: high-grade serous ovarian cancer

New research shows that removing the chromatin remodeler ALC1 sensitizes a broad range of ovarian cancer models to PARP inhibitors ...

A multi-omics study combining genomics and spatial transcriptomics finds that BRCA-mutated high-grade serous ovarian cancers show stronger interferon and inflammatory ...

A retrospective single-center cohort of 128 patients associated frontline bevacizumab with longer overall survival in advanced ovarian cancer, while clear ...

A Mini Review finds that AI-assisted integration of genomic and spatial data may reveal lesion-specific biology in ovarian cancer liver ...

A detailed map of proteins on the surface of high-grade serous ovarian cancer cells has revealed that these tumors depend ...

New research shows that senescent cancer-associated fibroblasts in high-grade serous ovarian cancer secrete Tenascin-C, which activates SDC4-ERK signaling in tumor ...

New research shows that high-grade serous ovarian cancer cells can convert abundant adrenal 11-oxyandrogen precursors into the potent androgen 11-keto-testosterone, ...

A personalized dendritic cell neoantigen vaccine given to an ovarian cancer patient enabled Swiss researchers to track expanding T-cell clonotypes ...

In a finding that could reshape the search for new treatments against one of the deadliest gynecologic malignancies, researchers in ...

In the intricate landscape of cancer research, the relentless pursuit of understanding metastatic mechanisms has garnered significant attention. Recent findings ...